Showing results (1131-1140 of 4,634) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|December 10, 1999
Diazene JK-279: potential anticancer drugM Osmak, T Bordukalo, B Jernej, et al.
Anti-Cancer Drugs|April 11, 2000
Characterization of human lung cancer cells resistant to 4'-O-demethyl-4beta-(2"-nitro-4"-fluoroanilino)-4-desoxypodophyllotoxin , a unique compound in the epipodophyllotoxin antitumor classY Tachibana, X K Zhu, P Krishnan, et al.
Anti-Cancer Drugs|April 11, 2000
Antitumor activity of dextran derivatives immobilizing platinum complex (II)K Ichinose, N Tomiyama, M Nakashima, et al.
Anti-Cancer Drugs|April 11, 2000
Anticancer drug-induced apoptosis in human monocytic leukemic cell line U937 requires activation of endonuclease(s)P Shrivastava, A Sodhi, P Ranjan
Anti-Cancer Drugs|June 8, 2001
The urokinase plasminogen activator receptor (uPAR) as a target for the diagnosis and therapy of cancerA P Mazar
Anti-Cancer Drugs|June 8, 2001
Active transepithelial transport of irinotecan (CPT-11) and its metabolites by human intestinal Caco-2 cellsW Yamamoto, J Verweij, P de Bruijn, et al.
Anti-Cancer Drugs|June 8, 2001
(S)-(-)-Bromofosfamide (CBM-11): synthesis and antitumor activity and toxicity in miceK Misiura, R W Kinas, H Kuśnierczyk, et al.
Anti-Cancer Drugs|July 8, 2000
Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cellsC Jean-Decoster, L Brichese, J M Barret, et al.
Anti-Cancer Drugs|July 8, 2000
Preferential repair of the N-ras gene in K 562 cells after exposure to cisplatinW Dempke, W Voigt, A Grothey, et al.
Anti-Cancer Drugs|July 8, 2000
Synthesis and cytotoxic activity of thiazolyl indolequinonesC J Moody, J R Roffey, E Swann, et al.
Pageof 464